Open this publication in new window or tab >>
2022 (English) In: BIOLOGY OPEN, ISSN 2046-6390, Vol. 11, no 1, article id bio059049Article in journal (Refereed) Published
Abstract [en] V gamma 9V delta 2 T cells is the dominant gamma delta T cell subset in human blood. They are cytotoxic and activated by phosphoantigens whose concentrations are increased in cancer cells, making the cancer cells targets for V gamma 9V delta 2 T cell immunotherapy. For successful immunotherapy, it is important both to characterise V gamma 9V delta 2 T cell proliferation and optimise the assessment of their cytotoxic potential, which is the aim of this study. We found that supplementation with freshly thawed human serum potentiated V gamma 9V delta 2 T cell proliferation from peripheral mononuclear cells (PBMCs) stimulated with (E)-4-Hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) and consistently enabled V gamma 9V delta 2 T cell proliferation from cryopreserved PBMCs. In cryopreserved PBMCs the proliferation was higher than in freshly prepared PBMCs. In a panel of short-chain prenyl alcohols, monophosphates and diphosphates, most diphosphates and also dimethylallylmonophosphate stimulated V gamma 9V delta 2 T cell proliferation. We developed a method where the cytotoxicity of V gamma 9V delta 2 T cells towards adherent cells is assessed at the single cell level using flow cytometry, which gives more clear-cut results than the traditional bulk release assays. Moreover, we found that HMBPP enhances the V gamma 9V delta 2 T cell cytotoxicity towards colon cancer cells. In summary, we have developed an easily interpretable method to assess the cytotoxicity of V gamma 9V delta 2 T cells towards adherent cells, found that V gamma 9V delta 2 T cell proliferation can be potentiated by media-supplementation and how misclassification of non-responders may be avoided. Our findings will be useful in the further development of V gamma 9V delta 2 T cell immunotherapy.
Place, publisher, year, edition, pages
COMPANY BIOLOGISTS LTD, 2022
Keywords Colon cancer, Cytotoxicity assay, Phosphoantigens, Proliferation, V gamma 9Vd2 T cells
National Category
Immunology
Identifiers urn:nbn:se:uu:diva-467906 (URN) 10.1242/bio.059049 (DOI) 000752236200006 () 34994391 (PubMedID)
Funder Swedish Research Council, Dnr 2010-3258
2022-02-182022-02-182022-02-18 Bibliographically approved